Human STAT3 Protein, His Tag (MALS & SPR verified)
分子別名(Synonym)
STAT3, signal transducer and activator of transcription 3
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human STAT3, His Tag (ST3-H5149) is expressed from E. coli cells. It contains AA Gly 127 - Arg 688 (Accession # P40763-1).
Predicted N-terminus: Met
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the N-terminus.
The protein has a calculated MW of 66.4 kDa. The protein migrates as 66-70 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 150 mM NaCl, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
信號轉(zhuǎn)導(dǎo)子和轉(zhuǎn)錄激活子3(STAT3)調(diào)節(jié)對基本細(xì)胞過程(包括存活、增殖、自我更新、血管生成和免疫反應(yīng))重要的基因的表達(dá)。作為早期腫瘤診斷標(biāo)志物,組成型STAT3激活被認(rèn)為是模型系統(tǒng)中引起惡性轉(zhuǎn)化和腫瘤發(fā)展的充分因素。癌癥細(xì)胞中經(jīng)典的IL6/STAT3信號通路。IL-6與膜結(jié)合的IL-6受體α(IL-6R)和IL-6受體β(也稱為gp130)結(jié)合。IL-6/IL-6R/gp130復(fù)合物激活JAKs的磷酸化,隨后是STAT3的磷酸化和激活。然后,磷酸化的STAT3形成同二聚體并易位到細(xì)胞核中,與靶基因的啟動子區(qū)域結(jié)合并激活靶基因轉(zhuǎn)錄。
關(guān)鍵字: STAT3;STAT3蛋白;STAT3重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。